DekaBank Deutsche Girozentrale
BCAB icon

DekaBank Deutsche Girozentrale’s BioAtla BCAB Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-250
Closed -$95K – 1345
2022
Q3 		$95K Buy
+250
New +$81.8K ﹤0.01% 1303

Other funds holding BCAB

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

DekaBank Deutsche Girozentrale's BCAB Position: Q4 2022 in Review

DekaBank Deutsche Girozentrale sold out of BioAtla (BCAB) in Q4 2022, closing a stake of 250 shares — an estimated $95K sold.

DekaBank Deutsche Girozentrale first reported a position in BCAB in Q3 2022 and held it in 1 quarter. The position peaked at $95K in Q3 2022. 91 funds tracked by Wall St. Rank hold BCAB as of Q4 2022.

  • DekaBank Deutsche Girozentrale reported no remaining BioAtla position as of Q4 2022 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 250 BioAtla shares in Q4 2022, an estimated $95K.
  • DekaBank Deutsche Girozentrale first reported a position in BioAtla in Q3 2022 and held it in 1 quarter.
  • DekaBank Deutsche Girozentrale's BioAtla position peaked at $95K in Q3 2022.
  • 91 funds tracked by Wall St. Rank held BioAtla as of Q4 2022.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2022, filed 1 Feb 2023.